Wird geladen...
Soluble fibrinogen-like protein 2 levels are decreased in patients with ischemic heart failure and associated with cardiac function
Soluble fibrinogen-like protein 2 (sFGL2), as a novel effector of regulatory T cells (Tregs), exhibits immune regulatory activity in several inflammatory diseases. Immune activation and persistent inflammation participate in the progression of ischemic heart failure (IHF). The present study aimed to...
Gespeichert in:
| Veröffentlicht in: | Mol Med Rep |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8188637/ https://ncbi.nlm.nih.gov/pubmed/34109427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2021.12198 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|